Wybrane najnowsze publikacje naszych autorów

• Herbst R., John T., Grohé C., Goldman J., Kato T., Laktionov K., Bonanno L., Tiseo M., Majem M., Dómine M., Ahn M., Kowalski D., Pérol M., Sriuranpong V., Özgürou glu M., Bhetariya P., Markovets A., Rukazenkov Y., Muldoon C., Robichaux J., Hartmaier R., Tsuboi M., Wu Y.: Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer, Nature Medicine, 2025, DOI:10.1038/s41591-025-03577-y, IF: 58.7
• Blondeaux E., Sonnenblick A., Agostinetto E., Bas R., Kim H., Franzoi M., Bernstein-Molho R., Linn S., Kwong A., Pogoda K., Balmana J., Smeets A., Bajpai J., Moore H., Partridge A., Phillips K., Toss A., Rousset-Jablonski C., Peccatori F., Renaud T., Ferrari A., Paluch-Shimon S., Mando P., Lee J., Fruscio R., Cui W., Wong S., Vernieri C., Ruddy K., Dieci M., Matikas A., Rozenblit M., Guven D., Lee M., Villarreal-Garza C., Hwang S., De Marchis L., Puglisi F., Kemp Z., Meireles P., Parokonnaya A., Werutsky G., Okano M., Azim H., Mati K., Rosenberg S., Gelber R., Boni L., Lambertini M.: Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study, Lancet Oncology, 2025,, DOI:10.1016/S1470-2045(25)00152-4, IF: 41.6
• Hofer S., Pauli C., Bode B., Bonvalot S., Fotopoulou C., Gelderblom H., Haas R., Hardes J., Hohenberger P., Jakob J., Kunz W., Leithner A., Liegl-Atzwanger B., Lindner L., Miah A., Reichardt P., Rutkowski P., Schaarschmidt B., Scheinemann K., Szkandera J., Wardelmann E., Andreou D., Rothermundt C.: Conference on Challenges in Sarcoma (CCS) 2024 Expert Opinions on Non-Evidence-based Management Aspects, European Journal of Cancer, 2025, Numer artykułu: 115368, DOI:10.1016/j.ejca.2025.115368, IF: 7.6
• Bizzarri N., Guidi G., Pavone M., Pedone Anchora L., Rychlik A., Goglia M., Fanfani F., Scambia G., Querleu D.: Laparoscopic para-uterine lymphovascular tissue sentinel lymph node biopsy with indocyanine green in cervical cancer, International Journal of Gynecological Cancer, 2025, Numer artykułu: 101744, DOI:10.1016/j.ijgc.2025.101744, IF: 4.5
• Kotowicz B., Chojnacka M., Fuksiewicz M., Kucha P., Zagórowicz E.: Evaluation of the clinical utility of measuring serum infliximab and vedolizumab concentrations during monitoring of biologic therapy in patients with inflammatory bowel disease, Przegląd Gastroenterologiczny, Polski Klub Trzustkowy, 2025, DOI:10.5114/pg.2025.147747, IF: 1.7